No Carolina / NY / Florida
Ph: 561.316.3330

Noteworth Secures $5 Million in Funding

Editor: What To Know

  • The platform provides a number of beneficial capabilities including expanded access to care in order to eliminate the barriers to care by putting health services into the patient’s hands.
  • Noteworth states the funding will be used to expand operations of their digital medical technology and make strategic hires necessary to meet the growing demand from healthcare providers and patients.
  • “Their ability to provide unprecedented healthcare data collection, assessment and proactive intervention across all current digital healthcare information silos, consistent with our investment thesis focused on digital workflow transformation, is what prompted our investment in this critical technology that is modernizing healthcare delivery.

July 15, 2020

Noteworth, a first-of-its-kind Digital Healthcare platform for modernizing Digital Medicine delivery operations, announced a $5 million oversubscribed seed funding round led by Laconia Capital Group with participation from Draper Associates, Frontier Ventures, Techstars Ventures, Wavemaker360, Springtide Capital and others.

Noteworth states the funding will be used to expand operations of their digital medical technology and make strategic hires necessary to meet the growing demand from healthcare providers and patients.

With this new investment, the company will continue to build upon the delivery of Noteworth’s first-of-its-kind Digital Healthcare platform. The platform provides a number of beneficial capabilities including expanded access to care in order to eliminate the barriers to care by putting health services into the patient’s hands. One of the main goals for the company is working to extend patient engagement by providing clinicians with the tools to communicate directly with patients through video, chat, and push notifications. The Noteworth platform works to help reduce costs by decreasing readmissions and the use of high-cost services with timely interventions. In addition, Noteworth will help clinicians obtain new reimbursements to generate additional income for new streams of revenue.

“The positive response and support of our strategic investors reflect a shared belief that digital medicine is the future of healthcare delivery,” said Justin Williams, Co-founder, and CEO of Noteworth. “With this new round of funding, Noteworth will continue to establish our ability to quickly and efficiently help healthcare providers launch our digital medicine technology platform offering to better serve their patient populations remotely.”

“Noteworth is a rising star in the field of digital medicine,” said David Arcara, Managing Partner of Laconia Capital Group. “Their ability to provide unprecedented healthcare data collection, assessment and proactive intervention across all current digital healthcare information silos, consistent with our investment thesis focused on digital workflow transformation, is what prompted our investment in this critical technology that is modernizing healthcare delivery. Laconia invests in companies that pioneer the digital transformation from legacy software and manual workflow processes into 21st century cloud-based platforms.”

“At Draper Associates, we are looking for companies that can become fundamental to an industry,” said Tim Draper, Founder and Managing Partner of Draper Associates. “Noteworth is an easy to use system that monitors the patient’s progress, improves profitability for the caregiver and derives insightful data for health care generally. We expect every doctor and every patient to be a part of this easy-to-use communications tool.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy